These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 3092845)
1. [Abnormal 13C-palmitate breath test in epileptic patients treated with valproic acid]. Arimoto K; Sakuragawa N; Suehiro M; Watanabe H No To Hattatsu; 1986 Sep; 18(5):354-9. PubMed ID: 3092845 [No Abstract] [Full Text] [Related]
2. Abnormal 13C-fatty acid breath tests in patients treated with valproic acid. Arimoto K; Sakuragawa N; Suehiro M; Watanabe H J Child Neurol; 1988 Oct; 3(4):250-7. PubMed ID: 3143757 [TBL] [Abstract][Full Text] [Related]
3. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique. Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222 [TBL] [Abstract][Full Text] [Related]
4. [Colorimetric determination of chloramphenicol and its palmitate in pharmaceuticals]. Przyborowski L Acta Pol Pharm; 1976; 33(2):223-8. PubMed ID: 937026 [No Abstract] [Full Text] [Related]
5. Diagnosis and differentiation of fat malabsorption in children using 13C-labeled lipids: trioctanoin, triolein, and palmitic acid breath tests. Watkins JB; Klein PD; Schoeller DA; Kirschner BS; Park R; Perman JA Gastroenterology; 1982 May; 82(5 Pt 1):911-7. PubMed ID: 7060913 [TBL] [Abstract][Full Text] [Related]
6. Release of sodium diclofenac from vehicles prepared with hydrogenated soya lecithin and methyl palmitate. Takahashi K; Tamagawa S; Katagi T; Yoshitomi H; Nishihata T; Kamada A Chem Pharm Bull (Tokyo); 1988 Feb; 36(2):750-6. PubMed ID: 3409381 [No Abstract] [Full Text] [Related]
7. Effect of fatty acid chain length and saturation on the gastrointestinal handling and metabolic disposal of dietary fatty acids in women. Jones AE; Stolinski M; Smith RD; Murphy JL; Wootton SA Br J Nutr; 1999 Jan; 81(1):37-43. PubMed ID: 10341674 [TBL] [Abstract][Full Text] [Related]
8. The effect of valproic acid on sister chromatid exchange aberration frequency in epileptic children. Hu LJ; Lu XF; Lu BQ; Huang YQ Chin Med J (Engl); 1990 May; 103(5):415-7. PubMed ID: 2118059 [TBL] [Abstract][Full Text] [Related]
9. [Determination of the maturity of the fetal lung by analysing the palmitin acid concentration in the amniotic fluid]. Horváth I; Koloszár J; Fias I; Karácsony G; Méhes K Orv Hetil; 1976 Feb; 117(9):531-2. PubMed ID: 1256860 [No Abstract] [Full Text] [Related]
10. RELATIVE RATES OF OXIDATION OF PALMITATE-1-C14 BY WHITE BLOOD CELLS, RED CELLS AND PLATELETS OF RATS. HRACHOVEC JP Proc Soc Exp Biol Med; 1965 Feb; 118():328-33. PubMed ID: 14268613 [No Abstract] [Full Text] [Related]
11. A model for isotopic sampling and administration in constant infusion experiments: a test with 13C-palmitate. Goodenough RD; Wolfe RR Am J Clin Nutr; 1983 Jun; 37(6):1004-9. PubMed ID: 6846232 [TBL] [Abstract][Full Text] [Related]
12. [Determination of N-Dipropylacetamide serum concentration and its clinical significance in epileptic children]. Shi FL Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Aug; 19(4):217-20. PubMed ID: 3095059 [No Abstract] [Full Text] [Related]
14. Do epileptic children treated with valproate have a risk of excessive weight gain? Bosnak M; Dikici B; Haspolat K; Dagli A; Dikici S J Child Neurol; 2003 Apr; 18(4):306; author reply 306. PubMed ID: 12760438 [No Abstract] [Full Text] [Related]
15. Acute valproate-associated microvesicular steatosis: could the [13C]methionine breath test be useful to assess liver mitochondrial function? Spahr L; Negro F; Rubbia-Brandt L; Marinescu O; Goodman K; Jordan M; Frossard JL; Hadengue A Dig Dis Sci; 2001 Dec; 46(12):2758-61. PubMed ID: 11768270 [TBL] [Abstract][Full Text] [Related]
16. [Side effects of valproate in epileptic children]. John K; Ludwig U; Daute KH Kinderarztl Prax; 1987 Apr; 55(4):185-9. PubMed ID: 3110484 [No Abstract] [Full Text] [Related]
17. Thrombophilic risk factors in epileptic children treated with valproic Acid. Unal O; Deda G; Teber S; Ertem M; Akar N Pediatr Neurol; 2009 Feb; 40(2):102-6. PubMed ID: 19135623 [TBL] [Abstract][Full Text] [Related]
18. An Evaluation of Peripapillary Retinal Nerve Fiber Layer Thickness in Children With Epilepsy Receiving Treatment of Valproic Acid. Dereci S; Koca T; Akçam M; Türkyilmaz K Pediatr Neurol; 2015 Jul; 53(1):53-7. PubMed ID: 25979661 [TBL] [Abstract][Full Text] [Related]
19. [The effect of enkorat on the course of epilepsy in children]. Badalian LO; Temin PA; Iskander MB; Dunaevskaia GN; Mukhin KIu; Medvedev MI; Veselov NK; Filin VA; Aĭvazian SO Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(4):104-5. PubMed ID: 9281264 [No Abstract] [Full Text] [Related]
20. [The enkorat treatment of infantile spasms and the Lennox-Gastaut syndrome]. Badalian LO; Temin PA; Medvedev MI; Mukhin KIu; Iskander MB; Kharlamov DA; Veselov NK Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(6):28-33. PubMed ID: 7740870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]